SlideShare a Scribd company logo
1 of 28
The alterations of Ca2+/calmodulin/CaMKII/CaV1.2
 signaling in experimental models of Alzheimer’s
          disease and vascular dementia

  Dongyu Mina,b,1 , Feng Guoa,1 , Shu Zhuc , Xiaoxue Xud , Xiaoyuan Maoa
   , Yonggang Caoa , Xintong Lva , Q1 Qinghua Gaoa, Lei Wange, Tianbao
               Chene, Chris Shawe, Liying Haoa, Jiqun Cai
Manuela Jiménez Obando
Juan Sebastián Marín Cárdenas
           Molecular Biology
             III Semester
                  2013
INTRODUCTION

• Alteration in the intracellular          Proteins                            Funtion
  Calcium is involved in Alzheimer         L-type calcium channel (LTCC)       Survival and death transduction
                                                                               medaited by calcium.
  disease and vascular dementia.
                                           CaV1.2 channel                      Interfers in the effectively activate
                                                                               cAMP response element-binding
                                                                               (CREB)
• A lot of proteins are involved in this   CREB                                Mediates gene transcription.
  pathological mecanism.                   Calmodulin (CaM)                    Basic neuronal functions
                                           Calcium/calmodulin-dependent        Modulator of excitation-
                                           protein kinase II (CaMKII)          transcription coupling in neurons -
• The signaling                                                                synaptic plasticity
  Ca2+/calmodulin/CaMKII/CaV1.2 is         Brain-derived neurotrophic factor   Development, differentiation,
                                           (BDNF)                              maintenance and plasticity of brain
  really important in the Pathogenesis                                         function
  of Alzheimer disease.                    AB 1–42                             Major component of amyloid
                                                                               plaques, accumulates in neurons of
                                                                               Alzheimer’s disease brains
INTRODUCTION
• Alzheimer’s disease was first identified on 1906 -
  German physician, Dr. Alois Alzheimer.

• Abnormalities are deposits of the protein fragment 40–
  43 amino acid peptide called b-amyloid (beta-pleated
  sheet).

• Soluble beta-amyloid aggregates spontaneously into
  fibrils that are indistinguishable, it is thought that
  plaques result from raised b-amyloid levels.

• Strands of the protein tau when becomes hyper-
  phosphorylated and this less efficient binding to
  microtubules as well as evidence of nerve cell damage    http://www.memorydr.com/alz.htm


  and death in the brain.
INTRODUCTION
• Most common type of dementia-progressive deterioration of
  thinking abilities severe enough to interfere with social,
  occupational and intellectual functions.

• The term late-onset dementia refers to intellectual deterioration
  which occurs after the age of 65 years (Vascular, Lewy bodies
  (DLB), Mixed dementia, Parkinson’s disease, Frontotemporal lobar
  degeneration, Creutzfeldt-Jakob)

• Accounts for an estimated 60 to 80 percent of dementia cases.

• Genetics factors (Prenilysin 1-2, Tau, Calmodulin,
  Apolipoprotein-E-increase in the density of beta-amyloid
  deposits)-non genetics Aetiology.
                                                                      http://year9diseases.wikispaces.com/Alzheimer's+disease
INTRODUCTION

                                                                           • Vascular dementia is impaired the
                                                                             judgment or ability to make plans is
                                                                             more likely to be the initial symptom, as
                                                                             opposed to the memory loss often
                                                                             associated with the initial symptoms of
                                                                             Alzheimer disease.
                                                                           • Occurs because of brain injuries such
                                                                             as microscopic bleeding and blood
                                                                             vessel blockage. The location of the
                                                                             brain injury determines how the
                                                                             individual’s thinking and physical
http://neuropsicologica.blogspot.com/2010/06/la-demencia-vascular-i.html
                                                                             functioning are affected.
Ca2+/calmodulin/CaMKII/CaV1.2

                                Proteins                            Funtion
There       are    important    L-type calcium channel (LTCC)       Survival and death transduction
                                                                    medaited by calcium.
interactions between Ca2+       CaV1.2 channel                      Interfers in the effectively
                                                                    activate cAMP response element-
and       others     proteins                                       binding (CREB)

mediateing some cellular        CREB                                Mediates gene transcription.
                                Calmodulin (CaM)                    Basic neuronal functions
signaling that prevent the      Calcium/calmodulin-dependent        Modulator of excitation-

cellular damage avoiding the    protein kinase II (CaMKII)          transcription coupling in neurons
                                                                    -synaptic plasticity

alterations presented in the    Brain-derived neurotrophic factor
                                (BDNF)
                                                                    Development, differentiation,
                                                                    maintenance and plasticity of
Alzheimer disease.                                                  brain function
                                AB 1–42                             Major component of amyloid
                                                                    plaques, accumulates in neurons
                                                                    of Alzheimer’s disease brains
Ca2+/calmodulin/CaMKII/CaV1.2


                           Ca2+   Development, differentiation, maintenance
                                  and plasticity of brain function

                 LTCC
                                   Membrane

      Ca2+


                     CREB              BDNF
CaM

                                       Nucleus
                P ser 33
       CaMKII
General objective.


The general objective is to determinate the alterations of
Ca2+/calmodulin/CaMKII/CaV1.2 signaling in experimental
  models of Alzheimer’s disease and vascular dementia


Evaluate the interacations between
this proteins and the Ca2+
concentrations in vascular and
Alzheimer dementia to dilucidate
the correct signaling process that
have not been well determinated.     http://www.elmundo.es/elmundosalud/2008/02/06/neurociencia/1202303660.html
Materiales y metodos.


Etica: el estudio fue aprovado segun las
especificaciones propias del pais para las
investigaciones en el area de la salud.

Cultivo animal: se utilizaron ciertos ratones.
• Macho de nueve meses de edad APP/PS1-
    Tg
• Tipo salvaje-jerbos.                           http://es.123rf.com/photo_9818004_un-raton-de-cosecha-trepar-a-traves-de-un-campo-de-trigo-antes-de-
                                                 tiempo-de-cosecha.html
Materiales y métodos.



Induccion de isquemia global: los ratones se anestesiaron
anteriormente, luego se indujo la isquemia utilizando pinzas arteriales, a
los 10 minutos, se retiraron las pinzas para reestablecer el flujo. El
raton de caracter control se hizo lo mismo pero son compresión
carotidea.
• Con esto se pretendio inducir la isquemia cerebral y así
     evaluar los parámentros de la investigación con el modelo de
     demencia vascular.
Materiales y métodos.


Tinción de Nissl: posterior a la aplicacion del test de Morris , se
extrageron todos los cerebros y fijados durante un dia, luego, se paso a
una solucion con sucrosa, se tomaron los fragmentos con el micrometro
y se aplico la tinsion de Nissl.
• Se realizó para evaluar la presencia de los cuerpos de Nissl que son
    poliribosomas libres en el citoplasma principalmente en el soma y
    que cuando hay alteraciones patológicas se encuentran disminuidos.




                          http://sosbiologiacelularytisular.blogspot.com/2010/09/biologia-celular-cuerpos-de-nissl.html
Materiales y métodos.

Cultivo primario y viabilidad celular
neuronal.
• Células de un día de viejas del hipocampo fueron
  sumergidas en una solución y luego trasladadas
  a una caja Petri con suero bovino.

• 24 horas después el suero fue reemplazado por
  suero neurobasal. Nueve días después fue de
  nuevo reemplazado por el suero inicial y se le
  sumo AB 1–42 a diferentes concentraciones (0,
  116 1, 2, 4, 8, and 16 M).
                                                     http://www.google.com.co/imgres?q=mtt+method&um=1&hl=es-
                                                     419&sa=N&biw=1366&bih=667&tbm=isch&tbnid=8LdA2P_Xno3QNM:&imgrefurl=http://2010.igem.org/Team:Freiburg_Bioware/Filelist2&docid=mUBnj6GB6Em2BM&imgurl=http://2010.igem.or
                                                     g/wiki/images/c/ca/Freiburg10_MTT_method.png&w=543&h=458&ei=mt8_UaiBD5Ci8ASRh4D4BA&zoom=1&ved=1t:3588,r:0,s:0,i:77&iact=rc&dur=1398&page=1&tbnh=180&tbnw=213&start=
                                                     0&ndsp=17&tx=95&ty=118




• Se aplicó método MTT y se midió a 570nm.
Materiales y métodos.

     Medición de Calcio intracelular.
Al noveno, las neuronas del control y pre-
tratadas con AB 1-42 (4uM) durante 24 h se
pusieron en un suero sin medio de crecimiento
por 30 min a 37 centígrados. La concentración
intracelular de Ca2 + se expresó como la
intensidad de fluorescencia por el software
(EZ-C1 3,70 128 FreeViewer NIKON) y la
intensidad media de cada neurona se calculó.

                         Fluo-3/AM disuelto
Calcuio         +
                         en DMSO
                                                Fluorecencia
           Ester hidrolidazo
Materiales y métodos.

                                  Western blot:
• Los tejidos del hipocampo de jerbos, ratones y los cultivos de neuronas tratadas 24 h con
  AB 1-42 fueron utilizados.
                                                                                                Conejo anti-CREB, de
• Los niveles totales de proteína se determinaron utilizando un kit de ensayo de proteína BCA   conejo anti-BDNF,
                                                                                                ratón anti Cav1.2, de
  además Los anticuerpos primarios.                                                             conejo anti-p-
                                                                                                CaMKII, ratón anti-
                                                                                                CaM y de conejo
                                                                                                beta-Actina.
• Las membranas se incubaron con HRP(Peroxidasa de rábano picante)-conjugado con
  anticuerpos secundarios durante 1 hora a temperatura ambiente.

•    La inmunodetección se realizó con quimioluminiscencia seguido de seguro a película de
    rayos X .

• Todos los datos se analizaron por software Quantity One (BioRad).
Materiales y métodos.
Materiales y métodos.

Inmunofluoresencia
                                                                Ratones
• Ratones anestesiados y perfundidos intracardialmente
  con paraformaldehído- anestesia.
• Secciones coronales del cerebro, después se incubaron      Células propias
  noche en una mezcla de anticuerpos, ratón anti-Cav1.2 y
  de conejo FITC y Cy3.
• Cortes se incubaron anticuerpos anti-ratón y anti-
  conejo durante 2 ha temperatura ambiente.
                                                            Anticuerpos-análisis
• La tinción nuclear se consiguió con DAPI. Fueron
  examinados utilizando microscopia de barrido laser, se
  documento los resultados con softhware.
NEURONA + Aβ 1–42




   ↓ VIABILIDAD
     CELULAR
  (DEPENDIENDO
   DE LA DOSIS)
NEURONAS   NEURONAS TRATADAS
NORMALES     CON Aβ 1–42 (4μM)



              ↑ [Ca+2 ]i
APP/PS1:

  CaMKII,
  Cav1.2




VD Gerbils

   CaMKII,
   Cav1.2
Who?                                   What did they say?                      Agree   Disagree

• [2] K.A. Bruggink, W. Jongbloed, E.A.            “APP/PS1 mice revealed significant deficits
   Biemans, R. Veerhuis, J.A. Claassen, H.B.       in hippocampal basal synaptic transmission
   Kuiperij, M.M. Verbeek, Amyloid- oligomer
   detection by ELISA in cerebrospinal fluid and
                                                   (BST), long-term potentiation (LTP) and
   brain tissue, Analytical Biochemistry 433       memory [15] and the expression of Aβ 1–42
   (2012) 112–120.                                 is increased in the brain [2].”
• [15] R.S. Reiserer, F.E. Harrison, D.C.
   Syverud, M.P. McDonald, Impaired spatial
   learn- 381
   ing       in      the       APPSwe          +
PSEN1DeltaE9 bigenic mouse model of
Alzheimer’s disease, 382
Genes, Brain and Behavior 6 (2007) 54–65.
A. Kamata, H. Sakagami, H. Tokumitsu, M. Sanda,    “CaMKII, a kinase that is highly-
Y. Owada, K. Fukunaga, H. Kondo, Distinct          concentrated in postsynaptic regions and is
developmental expression of two isoforms of        activated by Ca2+/CaM, is thought to have
Ca2+/calmodulin- dependent protein kinase
kinases and their involvement in hippocampal
                                                   a key role in this alteration [8] “
dendritic formation, Neuroscience Letters 423
(2007) 143–148.
Who?                                    What did they say?               Agree   Disagree

Y. Yamamoto, N. Shioda, F. Han, S. “Cerebral ischemia reduced p-CaMKII levels
Moriguchi, A. Nakajima, A. Yokosuka, Y. in the hippocampal CA1 region “
Mimaki, Y. Sashida, T. Yamakuni, Y. Ohizumi,
K. Fukunaga, Nobiletin improves brain
ischemia-induced learning and memory
deficits through stimulation of CaMKII and
CREB phosphorylation, Brain Research
1295 (2009) 218–229.
D. Zhao, J.B. Watson, C.W. Xie, Amyloid beta   “Inhibition of CaMKII-dependent protein
prevents activation of calcium/calmodulin-     phosphorylation was found to be essential
dependent protein kinase II and AMPA           for A-induced LTP and memory
receptor phos- phorylation during              Deficits”
hippocampal long-term potentiation,
Journal of Neurophysiology 92 (2004)
2853–2858.
The findings of the present study could be the beginning of new
         therapeutic targets both in Alzehimer disease and vascular
         dementia.


Biomolecular techniques like Western Blot, are essential in the
development of investigations like the one in this article, and if
we do a correct use of them, the advances will be bigger and
would continue contributing to the science.
This study can show us the important role of calcium in the real
         homestasis in brain cells , an clear up the complex
         phisiopathologic mecanism in the Alzheimer disease and more
         clues of the vascuar dementia.



The importance of the inglish in the biomedical sciences is very
significant to know the most recently news and knowdge.
REFERENCES
• Hutton M ,Hardy J (1997) The presenilins and Alzheimer’s
  disease.Human Molecular Genetics 6: 1639–1646.

More Related Content

Viewers also liked (20)

Zinc-it export 2013
Zinc-it export 2013 Zinc-it export 2013
Zinc-it export 2013
 
Rs 14.03.2013
Rs 14.03.2013Rs 14.03.2013
Rs 14.03.2013
 
Microsoft Access
Microsoft AccessMicrosoft Access
Microsoft Access
 
Histerectomia supracervical laparoscopicaa
Histerectomia supracervical laparoscopicaaHisterectomia supracervical laparoscopicaa
Histerectomia supracervical laparoscopicaa
 
E Book Ca E Learning Excerto
E Book Ca E Learning ExcertoE Book Ca E Learning Excerto
E Book Ca E Learning Excerto
 
Fhsk2 hu7 3
Fhsk2 hu7 3Fhsk2 hu7 3
Fhsk2 hu7 3
 
La Importancia De La Web 2
La Importancia De La Web 2La Importancia De La Web 2
La Importancia De La Web 2
 
Inclusao Digital
Inclusao DigitalInclusao Digital
Inclusao Digital
 
Curadoria digital Recife
Curadoria digital RecifeCuradoria digital Recife
Curadoria digital Recife
 
El delfin.pptx alessi informatica
El delfin.pptx alessi informaticaEl delfin.pptx alessi informatica
El delfin.pptx alessi informatica
 
La calavera
La calaveraLa calavera
La calavera
 
Postal De Natal
Postal De NatalPostal De Natal
Postal De Natal
 
A casa do relógio porto
A casa do relógio   portoA casa do relógio   porto
A casa do relógio porto
 
Reglas basicas para la tercera edad1
Reglas basicas para la tercera edad1Reglas basicas para la tercera edad1
Reglas basicas para la tercera edad1
 
O melhor conselho_de_um_pai
O melhor conselho_de_um_paiO melhor conselho_de_um_pai
O melhor conselho_de_um_pai
 
Iso 9001 2008-7-6-mio-v2
Iso 9001 2008-7-6-mio-v2Iso 9001 2008-7-6-mio-v2
Iso 9001 2008-7-6-mio-v2
 
Boletín febrero 2015
Boletín febrero 2015Boletín febrero 2015
Boletín febrero 2015
 
Tabla
TablaTabla
Tabla
 
áLbum esdras
áLbum esdrasáLbum esdras
áLbum esdras
 
Cocodrilo
CocodriloCocodrilo
Cocodrilo
 

Similar to Alterations of Ca2+/calmodulin signaling in Alzheimer's and vascular dementia models

Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's diseasejusiin
 
Apoptosis and neurological disorders
Apoptosis and neurological disordersApoptosis and neurological disorders
Apoptosis and neurological disordersNeurologyKota
 
Microbial BBB Astroglia Neuron
Microbial BBB Astroglia Neuron Microbial BBB Astroglia Neuron
Microbial BBB Astroglia Neuron Ersifa Fatimah
 
Alzheimer's disease overview
Alzheimer's disease overviewAlzheimer's disease overview
Alzheimer's disease overviewAndrewKim374
 
Biochemistry of Alzheimers disease
Biochemistry of Alzheimers diseaseBiochemistry of Alzheimers disease
Biochemistry of Alzheimers diseaseAshok Katta
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer diseaseESHIKAJAIN5
 
Calcitonin mutations, their relationship with arrhytmia and translation error...
Calcitonin mutations, their relationship with arrhytmia and translation error...Calcitonin mutations, their relationship with arrhytmia and translation error...
Calcitonin mutations, their relationship with arrhytmia and translation error...María Camila Vélez P
 
Pathophysiology of alzheimer
Pathophysiology of alzheimerPathophysiology of alzheimer
Pathophysiology of alzheimerm_sumbe
 
Alzforum Berislav Zlokovic
Alzforum Berislav ZlokovicAlzforum Berislav Zlokovic
Alzforum Berislav ZlokovicAlzforum
 
Neurodegerative Disorder.pptx
Neurodegerative Disorder.pptxNeurodegerative Disorder.pptx
Neurodegerative Disorder.pptxBharatipathopunu
 
Neurodegerative Disorder.pptx
Neurodegerative Disorder.pptxNeurodegerative Disorder.pptx
Neurodegerative Disorder.pptxBVDUPathology1
 
Neurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptxNeurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptxRBalaraman4
 
Central nervous system 2
Central nervous system 2Central nervous system 2
Central nervous system 2Dr. Arpit Gohel
 
Alzheimers disease by Ritika soni
Alzheimers disease by Ritika soniAlzheimers disease by Ritika soni
Alzheimers disease by Ritika soniShimla
 

Similar to Alterations of Ca2+/calmodulin signaling in Alzheimer's and vascular dementia models (20)

Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Apoptosis and neurological disorders
Apoptosis and neurological disordersApoptosis and neurological disorders
Apoptosis and neurological disorders
 
Microbial BBB Astroglia Neuron
Microbial BBB Astroglia Neuron Microbial BBB Astroglia Neuron
Microbial BBB Astroglia Neuron
 
Alzheimer's disease overview
Alzheimer's disease overviewAlzheimer's disease overview
Alzheimer's disease overview
 
Biochemistry of Alzheimers disease
Biochemistry of Alzheimers diseaseBiochemistry of Alzheimers disease
Biochemistry of Alzheimers disease
 
Alzheimer's__CHANDAN.pptx
Alzheimer's__CHANDAN.pptxAlzheimer's__CHANDAN.pptx
Alzheimer's__CHANDAN.pptx
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer disease
 
Calcitonin mutations, their relationship with arrhytmia and translation error...
Calcitonin mutations, their relationship with arrhytmia and translation error...Calcitonin mutations, their relationship with arrhytmia and translation error...
Calcitonin mutations, their relationship with arrhytmia and translation error...
 
Pathophysiology of alzheimer
Pathophysiology of alzheimerPathophysiology of alzheimer
Pathophysiology of alzheimer
 
AN_A&D2016
AN_A&D2016AN_A&D2016
AN_A&D2016
 
Cp gdementiafor kelantan2012
Cp gdementiafor kelantan2012Cp gdementiafor kelantan2012
Cp gdementiafor kelantan2012
 
Alzforum Berislav Zlokovic
Alzforum Berislav ZlokovicAlzforum Berislav Zlokovic
Alzforum Berislav Zlokovic
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Neurodegerative Disorder.pptx
Neurodegerative Disorder.pptxNeurodegerative Disorder.pptx
Neurodegerative Disorder.pptx
 
Neurodegerative Disorder.pptx
Neurodegerative Disorder.pptxNeurodegerative Disorder.pptx
Neurodegerative Disorder.pptx
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer disease
 
3429390.ppt
3429390.ppt3429390.ppt
3429390.ppt
 
Neurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptxNeurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptx
 
Central nervous system 2
Central nervous system 2Central nervous system 2
Central nervous system 2
 
Alzheimers disease by Ritika soni
Alzheimers disease by Ritika soniAlzheimers disease by Ritika soni
Alzheimers disease by Ritika soni
 

Alterations of Ca2+/calmodulin signaling in Alzheimer's and vascular dementia models

  • 1. The alterations of Ca2+/calmodulin/CaMKII/CaV1.2 signaling in experimental models of Alzheimer’s disease and vascular dementia Dongyu Mina,b,1 , Feng Guoa,1 , Shu Zhuc , Xiaoxue Xud , Xiaoyuan Maoa , Yonggang Caoa , Xintong Lva , Q1 Qinghua Gaoa, Lei Wange, Tianbao Chene, Chris Shawe, Liying Haoa, Jiqun Cai
  • 2. Manuela Jiménez Obando Juan Sebastián Marín Cárdenas Molecular Biology III Semester 2013
  • 3. INTRODUCTION • Alteration in the intracellular Proteins Funtion Calcium is involved in Alzheimer L-type calcium channel (LTCC) Survival and death transduction medaited by calcium. disease and vascular dementia. CaV1.2 channel Interfers in the effectively activate cAMP response element-binding (CREB) • A lot of proteins are involved in this CREB Mediates gene transcription. pathological mecanism. Calmodulin (CaM) Basic neuronal functions Calcium/calmodulin-dependent Modulator of excitation- protein kinase II (CaMKII) transcription coupling in neurons - • The signaling synaptic plasticity Ca2+/calmodulin/CaMKII/CaV1.2 is Brain-derived neurotrophic factor Development, differentiation, (BDNF) maintenance and plasticity of brain really important in the Pathogenesis function of Alzheimer disease. AB 1–42 Major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains
  • 4. INTRODUCTION • Alzheimer’s disease was first identified on 1906 - German physician, Dr. Alois Alzheimer. • Abnormalities are deposits of the protein fragment 40– 43 amino acid peptide called b-amyloid (beta-pleated sheet). • Soluble beta-amyloid aggregates spontaneously into fibrils that are indistinguishable, it is thought that plaques result from raised b-amyloid levels. • Strands of the protein tau when becomes hyper- phosphorylated and this less efficient binding to microtubules as well as evidence of nerve cell damage http://www.memorydr.com/alz.htm and death in the brain.
  • 5. INTRODUCTION • Most common type of dementia-progressive deterioration of thinking abilities severe enough to interfere with social, occupational and intellectual functions. • The term late-onset dementia refers to intellectual deterioration which occurs after the age of 65 years (Vascular, Lewy bodies (DLB), Mixed dementia, Parkinson’s disease, Frontotemporal lobar degeneration, Creutzfeldt-Jakob) • Accounts for an estimated 60 to 80 percent of dementia cases. • Genetics factors (Prenilysin 1-2, Tau, Calmodulin, Apolipoprotein-E-increase in the density of beta-amyloid deposits)-non genetics Aetiology. http://year9diseases.wikispaces.com/Alzheimer's+disease
  • 6. INTRODUCTION • Vascular dementia is impaired the judgment or ability to make plans is more likely to be the initial symptom, as opposed to the memory loss often associated with the initial symptoms of Alzheimer disease. • Occurs because of brain injuries such as microscopic bleeding and blood vessel blockage. The location of the brain injury determines how the individual’s thinking and physical http://neuropsicologica.blogspot.com/2010/06/la-demencia-vascular-i.html functioning are affected.
  • 7. Ca2+/calmodulin/CaMKII/CaV1.2 Proteins Funtion There are important L-type calcium channel (LTCC) Survival and death transduction medaited by calcium. interactions between Ca2+ CaV1.2 channel Interfers in the effectively activate cAMP response element- and others proteins binding (CREB) mediateing some cellular CREB Mediates gene transcription. Calmodulin (CaM) Basic neuronal functions signaling that prevent the Calcium/calmodulin-dependent Modulator of excitation- cellular damage avoiding the protein kinase II (CaMKII) transcription coupling in neurons -synaptic plasticity alterations presented in the Brain-derived neurotrophic factor (BDNF) Development, differentiation, maintenance and plasticity of Alzheimer disease. brain function AB 1–42 Major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains
  • 8. Ca2+/calmodulin/CaMKII/CaV1.2 Ca2+ Development, differentiation, maintenance and plasticity of brain function LTCC Membrane Ca2+ CREB BDNF CaM Nucleus P ser 33 CaMKII
  • 9. General objective. The general objective is to determinate the alterations of Ca2+/calmodulin/CaMKII/CaV1.2 signaling in experimental models of Alzheimer’s disease and vascular dementia Evaluate the interacations between this proteins and the Ca2+ concentrations in vascular and Alzheimer dementia to dilucidate the correct signaling process that have not been well determinated. http://www.elmundo.es/elmundosalud/2008/02/06/neurociencia/1202303660.html
  • 10. Materiales y metodos. Etica: el estudio fue aprovado segun las especificaciones propias del pais para las investigaciones en el area de la salud. Cultivo animal: se utilizaron ciertos ratones. • Macho de nueve meses de edad APP/PS1- Tg • Tipo salvaje-jerbos. http://es.123rf.com/photo_9818004_un-raton-de-cosecha-trepar-a-traves-de-un-campo-de-trigo-antes-de- tiempo-de-cosecha.html
  • 11. Materiales y métodos. Induccion de isquemia global: los ratones se anestesiaron anteriormente, luego se indujo la isquemia utilizando pinzas arteriales, a los 10 minutos, se retiraron las pinzas para reestablecer el flujo. El raton de caracter control se hizo lo mismo pero son compresión carotidea. • Con esto se pretendio inducir la isquemia cerebral y así evaluar los parámentros de la investigación con el modelo de demencia vascular.
  • 12. Materiales y métodos. Tinción de Nissl: posterior a la aplicacion del test de Morris , se extrageron todos los cerebros y fijados durante un dia, luego, se paso a una solucion con sucrosa, se tomaron los fragmentos con el micrometro y se aplico la tinsion de Nissl. • Se realizó para evaluar la presencia de los cuerpos de Nissl que son poliribosomas libres en el citoplasma principalmente en el soma y que cuando hay alteraciones patológicas se encuentran disminuidos. http://sosbiologiacelularytisular.blogspot.com/2010/09/biologia-celular-cuerpos-de-nissl.html
  • 13. Materiales y métodos. Cultivo primario y viabilidad celular neuronal. • Células de un día de viejas del hipocampo fueron sumergidas en una solución y luego trasladadas a una caja Petri con suero bovino. • 24 horas después el suero fue reemplazado por suero neurobasal. Nueve días después fue de nuevo reemplazado por el suero inicial y se le sumo AB 1–42 a diferentes concentraciones (0, 116 1, 2, 4, 8, and 16 M). http://www.google.com.co/imgres?q=mtt+method&um=1&hl=es- 419&sa=N&biw=1366&bih=667&tbm=isch&tbnid=8LdA2P_Xno3QNM:&imgrefurl=http://2010.igem.org/Team:Freiburg_Bioware/Filelist2&docid=mUBnj6GB6Em2BM&imgurl=http://2010.igem.or g/wiki/images/c/ca/Freiburg10_MTT_method.png&w=543&h=458&ei=mt8_UaiBD5Ci8ASRh4D4BA&zoom=1&ved=1t:3588,r:0,s:0,i:77&iact=rc&dur=1398&page=1&tbnh=180&tbnw=213&start= 0&ndsp=17&tx=95&ty=118 • Se aplicó método MTT y se midió a 570nm.
  • 14. Materiales y métodos. Medición de Calcio intracelular. Al noveno, las neuronas del control y pre- tratadas con AB 1-42 (4uM) durante 24 h se pusieron en un suero sin medio de crecimiento por 30 min a 37 centígrados. La concentración intracelular de Ca2 + se expresó como la intensidad de fluorescencia por el software (EZ-C1 3,70 128 FreeViewer NIKON) y la intensidad media de cada neurona se calculó. Fluo-3/AM disuelto Calcuio + en DMSO Fluorecencia Ester hidrolidazo
  • 15. Materiales y métodos. Western blot: • Los tejidos del hipocampo de jerbos, ratones y los cultivos de neuronas tratadas 24 h con AB 1-42 fueron utilizados. Conejo anti-CREB, de • Los niveles totales de proteína se determinaron utilizando un kit de ensayo de proteína BCA conejo anti-BDNF, ratón anti Cav1.2, de además Los anticuerpos primarios. conejo anti-p- CaMKII, ratón anti- CaM y de conejo beta-Actina. • Las membranas se incubaron con HRP(Peroxidasa de rábano picante)-conjugado con anticuerpos secundarios durante 1 hora a temperatura ambiente. • La inmunodetección se realizó con quimioluminiscencia seguido de seguro a película de rayos X . • Todos los datos se analizaron por software Quantity One (BioRad).
  • 17. Materiales y métodos. Inmunofluoresencia Ratones • Ratones anestesiados y perfundidos intracardialmente con paraformaldehído- anestesia. • Secciones coronales del cerebro, después se incubaron Células propias noche en una mezcla de anticuerpos, ratón anti-Cav1.2 y de conejo FITC y Cy3. • Cortes se incubaron anticuerpos anti-ratón y anti- conejo durante 2 ha temperatura ambiente. Anticuerpos-análisis • La tinción nuclear se consiguió con DAPI. Fueron examinados utilizando microscopia de barrido laser, se documento los resultados con softhware.
  • 18. NEURONA + Aβ 1–42 ↓ VIABILIDAD CELULAR (DEPENDIENDO DE LA DOSIS)
  • 19. NEURONAS NEURONAS TRATADAS NORMALES CON Aβ 1–42 (4μM) ↑ [Ca+2 ]i
  • 20.
  • 21. APP/PS1: CaMKII, Cav1.2 VD Gerbils CaMKII, Cav1.2
  • 22. Who? What did they say? Agree Disagree • [2] K.A. Bruggink, W. Jongbloed, E.A. “APP/PS1 mice revealed significant deficits Biemans, R. Veerhuis, J.A. Claassen, H.B. in hippocampal basal synaptic transmission Kuiperij, M.M. Verbeek, Amyloid- oligomer detection by ELISA in cerebrospinal fluid and (BST), long-term potentiation (LTP) and brain tissue, Analytical Biochemistry 433 memory [15] and the expression of Aβ 1–42 (2012) 112–120. is increased in the brain [2].” • [15] R.S. Reiserer, F.E. Harrison, D.C. Syverud, M.P. McDonald, Impaired spatial learn- 381 ing in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer’s disease, 382 Genes, Brain and Behavior 6 (2007) 54–65. A. Kamata, H. Sakagami, H. Tokumitsu, M. Sanda, “CaMKII, a kinase that is highly- Y. Owada, K. Fukunaga, H. Kondo, Distinct concentrated in postsynaptic regions and is developmental expression of two isoforms of activated by Ca2+/CaM, is thought to have Ca2+/calmodulin- dependent protein kinase kinases and their involvement in hippocampal a key role in this alteration [8] “ dendritic formation, Neuroscience Letters 423 (2007) 143–148.
  • 23. Who? What did they say? Agree Disagree Y. Yamamoto, N. Shioda, F. Han, S. “Cerebral ischemia reduced p-CaMKII levels Moriguchi, A. Nakajima, A. Yokosuka, Y. in the hippocampal CA1 region “ Mimaki, Y. Sashida, T. Yamakuni, Y. Ohizumi, K. Fukunaga, Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation, Brain Research 1295 (2009) 218–229. D. Zhao, J.B. Watson, C.W. Xie, Amyloid beta “Inhibition of CaMKII-dependent protein prevents activation of calcium/calmodulin- phosphorylation was found to be essential dependent protein kinase II and AMPA for A-induced LTP and memory receptor phos- phorylation during Deficits” hippocampal long-term potentiation, Journal of Neurophysiology 92 (2004) 2853–2858.
  • 24. The findings of the present study could be the beginning of new therapeutic targets both in Alzehimer disease and vascular dementia. Biomolecular techniques like Western Blot, are essential in the development of investigations like the one in this article, and if we do a correct use of them, the advances will be bigger and would continue contributing to the science.
  • 25. This study can show us the important role of calcium in the real homestasis in brain cells , an clear up the complex phisiopathologic mecanism in the Alzheimer disease and more clues of the vascuar dementia. The importance of the inglish in the biomedical sciences is very significant to know the most recently news and knowdge.
  • 26.
  • 27.
  • 28. REFERENCES • Hutton M ,Hardy J (1997) The presenilins and Alzheimer’s disease.Human Molecular Genetics 6: 1639–1646.